Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.
about
Quantification of sleep behavior and of its impact on the cross-talk between the brain and peripheral metabolism.Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Obstructive sleep apnea and type 2 diabetes: is there a link?Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineEvaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension.Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome.Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome.World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease: part 4.Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea.Sleep and metabolic function.Risk of obstructive sleep apnea in obese and nonobese women with polycystic ovary syndrome and healthy reproductively normal women.Cardiometabolic aspects of the polycystic ovary syndrome.Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome.Sleep disturbances and insulin resistance.Polycystic ovary syndrome in 2011: Genes, aging and sleep apnea in polycystic ovary syndrome.The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.Effect of continuous positive airway pressure on leptin levels in patients with obstructive sleep apnea: a meta-analysis.Sleep apnea syndrome in endocrine clinics.What does a diagnostic label of 'polycystic ovary syndrome' really mean in adolescence? A review of current practice recommendations.Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology.Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature.Sleep disturbances in women with polycystic ovary syndrome.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Neutrophil leucocytosis and polycystic ovarian syndrome--could elevated noradrenaline levels due to obstructive sleep apnoea be a contributing mechanism?Association between continuous positive airway pressure and changes in serum leptin in patients with obstructive sleep apnoea: a meta-analysis.Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.Cardiometabolic risk in polycystic ovary syndrome.The Importance of Sleep Hygiene in Polycystic Ovary Syndrome from the View of Iranian Traditional Medicine and Modern Medicine
P2860
Q27021953-02AFE069-0519-46C4-9E0F-12C1E01077F3Q28390200-C8C79728-19F6-4271-983F-AE257627E6B4Q30463385-0BA80DC6-5EB5-4DFD-9293-BE97918E7B06Q30470637-AF1F4431-9B35-4AC8-AED2-DE9DAF15DB82Q33587845-21046356-9A0D-44CE-A9EC-2D8C69062201Q33727111-84F5A5C3-4309-470D-8D68-C759D41842AEQ34738226-744B3030-713D-46DE-ADA7-B472C4C544CDQ35204611-11D0848A-D28A-43D7-B8ED-2857A91D21A2Q35225508-1FD57978-C02F-4E38-9B2C-7B804B34486FQ35757344-F0CAA3F5-D4BF-4DE5-AD67-817643F5A0F5Q35786178-5219071E-D19D-4F32-82B8-14ED5651B222Q35798745-ED6AD951-1EBC-4C87-9623-BE4A4D112E2DQ36287892-0FF97CF6-86B7-4D35-A91C-7DFF710D3FEFQ36431402-73215A1F-442F-4355-83B6-9A8D77B74B60Q37939268-6D9FF370-6730-4062-8AD7-3A577F27EE74Q37969922-CE3DD9AE-69E3-4292-9B3F-D322F221C921Q38033647-0553CFD9-4688-4CAC-A534-6C38C22CD301Q38258968-2EC1615C-8ECA-4754-9696-BD984D69A7E5Q38295233-602B48BD-083C-48E8-BE4C-2D54001BACECQ38540035-46D3040A-1405-4305-B94C-35E525A17599Q38633475-E7B3DAEE-52C7-48F9-BE20-60F28C851C9DQ39391344-805A666D-206D-4761-8B42-4C186AFC0FFDQ39455340-30B9E89B-3372-4FDC-A658-6F26535D231BQ40679971-2FB5B870-1290-4FEC-8A49-4E96BC688446Q41640666-FFBAD402-86FD-4BA7-8B6A-9E1108044957Q44018035-F7965DB0-E159-459E-92A1-4E769A4C582EQ48127036-2CBC8D00-8719-4E65-B1BC-9546D04ABC90Q50024493-3B98FD05-B29B-40A7-98D8-9E8ED0806246Q50056959-D5C3D5F9-69C8-4658-B9AB-55B4C3EB7FA1Q55437110-932D38D2-7D3D-45D5-AB2B-06DC872D43C4Q59137568-180A7806-44A8-496A-9881-8E310AF91418
P2860
Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@ast
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@en
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@nl
type
label
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@ast
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@en
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@nl
prefLabel
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@ast
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@en
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@nl
P2093
P2860
P356
P1476
Treatment of obstructive sleep ...... ith polycystic ovary syndrome.
@en
P2093
David A Ehrmann
Esra Tasali
Florian Chapotot
Harry Whitmore
Rachel Leproult
P2860
P304
P356
10.1210/JC.2010-1187
P407
P577
2010-12-01T00:00:00Z